Elective conversion to sirolimus vs. continued tacrolimus in kidney transplantation (the 3c study): Results of a randomized trial

Elective conversion to sirolimus vs. continued tacrolimus in kidney transplantation (the 3c study): Results of a randomized trial

Bibliographic Details
Main Authors:	Haynes, R, Baigent, C, Harden, P, Landray, M, Friend, P
Format:	Conference item
Published:	Wiley 2017

Similar Items

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
by: Haynes, R, et al.
Published: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
by: Haynes, R, et al.
Published: (2014)

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
by: Carroll, R, et al.
Published: (2013)

Sirolimus in combination with low-dose extended-release tacrolimus in kidney transplant recipients
by: Zhi-yu Zou, et al.
Published: (2023-12-01)

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
by: Haynes, R, et al.
Published: (2014)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

Alemtuzumab and sirolimus in renal transplantation: six-year results of a single-arm prospective pilot study.
by: Sutherland, A, et al.
Published: (2014)

Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis
by: Morteza Arab Zozani, et al.
Published: (2015-08-01)

Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients
by: Herlinda Reyes-Pérez, et al.
Published: (2016-01-01)

Mycophenolate mofetil enhances the negative effects of sirolimus and tacrolimus on rat kidney cell metabolism.
by: Jelena Klawitter, et al.
Published: (2014-01-01)

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)

Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients
by: SHENG-WEN WU, et al.
Published: (2013-08-01)

Autophagy in kidney transplants of sirolimus treated recipients
by: Sagar Bhayana, et al.
Published: (2017-04-01)

Effect of tacrolimus on the results of living related kidney donor transplantation
by: V A Goriaĭnov, et al.
Published: (2014-06-01)

Sirolimus-Induced Rash in a Kidney Transplant Patient
by: Zachary Bruss, et al.
Published: (2022-09-01)

Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation—A Network Meta-Analysis
by: Sebastian Wolf, et al.
Published: (2022-07-01)

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
by: Aparna Wagle Shukla, et al.
Published: (2023-08-01)

Neprilysin inhibition in chronic kidney disease.
by: Judge, P, et al.
Published: (2014)

Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients
by: Karel Krejci, et al.
Published: (2016-09-01)

Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.
by: Flechner, S, et al.
Published: (2005)

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

Gut microbiota and tacrolimus dosing in kidney transplantation.
by: John R Lee, et al.
Published: (2015-01-01)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
by: Majda Sahman, et al.
Published: (2021-03-01)

Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial.
by: Max Plischke, et al.
Published: (2015-01-01)

Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
by: Xiaofeng Zeng, et al.
Published: (2022-07-01)

Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells.
by: Opas Traitanon, et al.
Published: (2015-01-01)

Tacrolimus monitoring in hair samples of kidney transplant recipients
by: Alexander Born, et al.
Published: (2023-12-01)

The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
by: Gerold Thölking, et al.
Published: (2021-07-01)

Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland
by: Marco Bonani, et al.
Published: (2021-02-01)

Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients
by: Michael Thomas Burke, MBBS, et al.
Published: (2017-07-01)

Efficacy of Prolonged-release Tacrolimus After Conversion From Immediate-release Tacrolimus in Kidney Transplantation: A Retrospective Analysis of Long-term Outcomes From the ADMIRAD Study
by: Dirk Kuypers, MD, PhD, et al.
Published: (2023-04-01)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
by: Holly Mansell, et al.
Published: (2022-07-01)

A case of tacrolimus-induced encephalopathy after kidney transplantation
by: Myoung Uk Kim, et al.
Published: (2011-01-01)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
by: Seung Seok Han, et al.
Published: (2012-09-01)

Estimation of Tacrolimus Clearance in Saudi Adult Kidney Transplant Recipients
by: Saeed Alqahtani, et al.
Published: (2021-01-01)

Immunosuppression with prolonged-release tacrolimus in kidney or liver transplantation in India
by: Dinesh Khullar, et al.
Published: (2017-01-01)

Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
by: Hee Jung Jeon, et al.
Published: (2018-08-01)

Combined microneedling with tacrolimus vs tacrolimus monotherapy for vitiligo treatment
by: Howyda M. Ebrahim, et al.
Published: (2021-11-01)

Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?
by: Paolo Carta, et al.
Published: (2020-05-01)

Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
by: Toqa El‐Nahhas, et al.
Published: (2022-01-01)